H3K27M突变质瘤:疾病定义和生物学基础
Amanda M Saratsis1, Truman Knowles2, Antonela Petrovic3
1Advocate Aurora Healthcare, Chicago, Illinois, USA.
Neuro-oncology
|October 11, 2023
概括
组织素H3K27M突变是儿科和成人高度质瘤 (HGGs) 的共同分子事件. 这种突变与HGG患者的生存率和治疗反应的恶化有关.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 高度质瘤 (HGG) 是儿童癌症死亡的主要原因,也是成年人常见的一种主要脑瘤.
- 儿科和成人HGG,曾经被认为是相似的,现在被认为是分子上不同的,需要量身定制的治疗.
- 在儿童和成人HGG中,像基因组H3K27M突变这样的共享分子事件正在出现.
研究的目的:
- 审查H3K27M突变儿科和成人质瘤的临床和生物学方面.
- 为了解H3K27M突变质瘤的当前研究和临床策略提供基础.
主要方法:
- 对H3K27M突变质瘤的临床特征和生物学基础的文献综述.
- 分析现有关于儿童和成人群体中H3K27M突变的流行率和影响的数据.
主要成果:
- H3K27M突变是Histone H3基因 (H3F3A或HIST1H3B) 中的一个体质误解突变,在多达80%的儿科扩散中线质瘤和60%的成人扩散质瘤中发现.
- 与H3K27M突变型瘤相比,H3K27M突变型瘤的整体存活率明显降低,治疗反应减少.
- 这种突变代表了一个关键的共享分子事件,弥合了不同的儿科和成人HGG分类.
结论:
- H3K27M突变是儿童和成人高度质瘤的重要子集中的关键分子驱动因素.
- 了解H3K27M突变质瘤的共享生物学对于开发有效的向治疗策略至关重要.
- 对H3K27M突变质瘤的进一步研究将为这些具有挑战性的脑瘤提供独特的临床管理方法.
更多相关视频
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
15.9K
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
13.5K
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
